Sujiraphong Pharkjaksu

Sujiraphong Pharkjaksu

Auto-generated profile, based on publicly available information

Sujiraphong Pharkjaksu

Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2018 in Nature
Verified
Journal Article
Closed access
PDF file
PPPipat Piewngam
Pipat Piewngam
YZYue Zheng
Yue Zheng
TNThuan H. Nguyen
Thuan H. Nguyen
SDSeth W. Dickey
Seth W. Dickey
HJHwang-Soo Joo
Hwang-Soo Joo
MOMichael Otto
Michael Otto

14 June 2019 in Frontiers in Microbiology
Verified
Journal Article
Open access
LPLinh Thi Truc Pham
Linh Thi Truc Pham
SPSujiraphong Pharkjaksu
Sujiraphong Pharkjaksu
PCPiriyaporn Chongtrakool
Piriyaporn Chongtrakool
KSKamol Suwannakarn
Kamol Suwannakarn
PNPopchai Ngamskulrungroj
Popchai Ngamskulrungroj
Candida albicans is one of the most common human fungal pathogens. Candidemia has significant mortality globally. No epidemiological study of C. albicans based on multilocus sequence typing (MLST) has been conducted in Thailand. Therefore, MLST was used to study the molecular epidemiology of C. albicans blood strains in a large Thai teaching hospital. In vitro virulence phenotypes and antifungal susceptibility testing by broth microdilution were also conducted. Forty-six C. albicans blood strains from 37 patients were collected from the Department of Microbiology, Siriraj Hospital, in 2016 and 2017. Most patients (71.8%) were more than 60 years old, and the case fatality rate was 54.8%. The male-to-female ratio was 5:3. Thirty-four diploid sequence types (DSTs), including six new DSTs, were identified, with DST2514 (8.7%) and DST2876 (8.7%) as the most common DSTs. Strains were clustered into nine clades. Unlike other studies of C. albicans blood strains in Asia, clade 17 was the most common (13 strains, 28.3%). Sequential allelic changes were evident in sequential strains from one patient. All strains produced phospholipase and hemolysin, while none produced proteinase. The ability to form biofilm was found in 82.6% of the strains. Clade 17 strains showed significantly stronger hemolytic activity than non–clade 17 strains (69.2% versus 27.3%; p = 0.022). However, no significant association existed between clades and patient mortalities. All were susceptible or wild type to anidulafungin (MIC range = 0.015–0.12 and GM = 0.030), micafungin (MIC range = ≤ 0.008–0.015 and GM = 0.008), caspofungin (MIC range = 0.008–0.12 and GM = 0.036), and amphotericin B (MIC range = 0.25–0.5 and GM = 0.381). Only one strain was resistant to voriconazole (MIC range = ≤ 0.008 to ≥ 8 and GM = 0.010) and fluconazole (MIC range = 0.12–16 and GM = 0.398). In conclusion, a high prevalence of clade 17 C. albicans blood strains was found in Thailand, in contrast to other Asian countries. This unique finding might be explained by the strong hemolytic activity that is required for bloodstream infection of C. albicans.

5 October 2020 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
SPSujiraphong Pharkjaksu
Sujiraphong Pharkjaksu
KKKyung J. Kwon-Chung
Kyung J. Kwon-Chung
JBJohn E. Bennett
John E. Bennett
PNPopchai Ngamskulrungroj
Popchai Ngamskulrungroj
Cryptococcosis has become a major global health problem since the advent of the HIV pandemic in 1980s. Although its molecular epidemiology is well-defined, using isolates recovered since then, no pre-HIV-pandemic era epidemiological data exist. We conducted a molecular epidemiological study using 228 isolates of the C. neoformans/C. gattii species complexes isolated before 1975. Genotypes were determined by URA5 restriction fragment length polymorphism analysis and multi-locus sequence typing. Population genetics were defined by nucleotide diversity measurements, neutrality tests, and recombination analysis. Growth at 37°C, melanin synthesis, capsule production, and urease activity as virulence factors were quantified. The pre-HIV-pandemic isolates consisted of 186 (81.5%) clinical, 35 (15.4%) environmental, and 7 (3.1%) veterinary isolates. Of those, 204 (89.5%) belonged to C. neoformans VNI (64.0%), VNII (14.9%) and VNIV (10.5%) while 24 (10.5%) belonged to C. gattii VGIII (7.5%), VGI (2.6%) and VGII (0.5%). Among the 47 sequence types (STs) identified, one of VNII and 8 of VNIV were novel. ST5/VNI (23.0%) in C. neoformans and ST75/VGIII (25.0%) in C. gattii were the most common STs in both species complexes. Among C. neoformans, VNIV had the highest genetic diversity (Hd = 0.926) and the minimum recombination events (Rm = 10), and clinical isolates had less genetic diversity (Hd = 0.866) than environmental (Hd = 0.889) and veterinary isolates (Hd = 0.900). Among C. gattii, VGI had a higher nucleotide diversity (π = 0.01436) than in VGIII (π = 0.00328). The high-virulence genotypes (ST5/VNI and VGIIIa/serotype B) did not produce higher virulence factors levels than other genotypes. Overall, high genetic variability and recombination rates were found for the pre-HIV-pandemic era among strains of the C. neoformans/C. gattii species complexes. Whole genome analysis and in vivo virulence studies would clarify the evolution of the genetic diversity and/or virulence of isolates of the C. neoformans/C. gattii species complexes during the pre- and post-HIV-pandemic eras. Since the beginning of the HIV pandemic in 1980, infections due to isolates of the Cryptococcus neoformans/C. gattii species complexes have caused many deaths worldwide, especially in the HIV-infected population. Annually, approximately one-third, of all AIDS-related deaths,—representing more than 1,000,000 cases,—are caused by cryptococcosis. Since 1980, extensive molecular epidemiological surveys have been conducted, and the VNI molecular type has been found to be responsible for more than 90% of cryptococcosis in HIV patients. Whether the high VNI prevalence is associated with the HIV pandemic remains controversial as information on the isolates of the pre-HIV pandemic era is lacking. Therefore, this study of the molecular epidemiology and in vitro characteristics of the strains from the pre-HIV-pandemic era was undertaken. We found that only 64% of cryptococcosis was caused by VNI, and 9 sequence types existed only in the pre-HIV pandemic era. Unlike what was already known about the strains collected during the HIV pandemic era, ST5 and VGIIIa,—supposedly high virulence genotypes,—did not express higher virulence factors than other genotypes. These results implied that the HIV pandemic altered both the molecular epidemiology and virulence of Cryptococcus neoformans/C. gattii species complexes have been altered during HIV pandemic. However, detailed mechanism of these alteration remains to be deciphered further.

21 March 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CHChanin Hatthakaroon
Chanin Hatthakaroon
SPSujiraphong Pharkjaksu
Sujiraphong Pharkjaksu
PCPiriyaporn Chongtrakool
Piriyaporn Chongtrakool
KSKamol Suwannakarn
Kamol Suwannakarn
PKPattarachai Kiratisin
Pattarachai Kiratisin
PNPopchai Ngamskulrungroj
Popchai Ngamskulrungroj
Despite the strong association between Cryptococcus neoformans infection and the Human immunodeficiency virus (HIV) status of patients globally, most cryptococcosis cases in Far East Asia occur in non-HIV individuals. Molecular epidemiological studies, using multilocus sequence typing (MLST), have shown that more than 95% of cryptococcal strains belong to a specific subtype of VNI. However, this association has never been specifically examined in other parts of Asia. Therefore, in this study, we investigated the VNIc/ST5 genotype distribution among cryptococcosis patients in Thailand. Fifty-one C. neoformans isolates were collected from clinical samples in Siriraj Hospital, Bangkok, Thailand. The strains were predominantly isolated from HIV-positive patients (88.57%) and all were molecular type VNI MATα. An MLST analysis identified five sequence types (ST) in Siriraj Hospital, of which ST4 (45.10%) and ST6 (35.29%) were most common, and ST5 (15.69%), ST32 (1.96%), and ST93 (1.96) were less common. Contrary to reports from Far East Asia, ST5 was predominantly (83.33%) found in HIV patients (P = 0.657), and there was no significant change in the prevalence of ST5 over the past 10 years (P = 0.548). A further analysis of comorbidities showed higher morbidity and delays in the cryptococcal diagnosis in patients with tuberculosis coinfection or without HIV. Our study suggests that although the Thai population is genetically closely related to the Far East Asian population, ST5 is not associated with non-HIV status in Thailand. Therefore, this association may not be related to the host’s genetic background. However, its mechanism remains unclear.

10 September 2017 in Medical Mycology
Verified
Journal Article
Closed access
PDF file
SPSujiraphong Pharkjaksu
Sujiraphong Pharkjaksu
PCPiriyaporn Chongtrakool
Piriyaporn Chongtrakool
KSKamol Suwannakarn
Kamol Suwannakarn
PNPopchai Ngamskulrungroj
Popchai Ngamskulrungroj
The Candida parapsilosis complex has been described as the second or third most common yeast species isolated from patients with bloodstream infections worldwide. This complex consists of three species: C. parapsilosis sensu stricto, C. orthopsilosis, and C. metapsilosis. The distribution of species in this complex has never been studied in Thailand. Here we investigated the molecular epidemiology, in vitro on virulence factors, and antifungal susceptibility profiles of isolates of these three species collected from patients in Siriraj Hospital, Thailand, from 2011 to 2015. Of the 96 C. parapsilosis complex isolates analyzed, 66 (68.75%) were identified as C. parapsilosis sensu stricto, 28 (29.17%) as C. orthopsilosis, and two (2.08%) as C. metapsilosis. Most strains were isolated from blood (81.25%). Proteinase activity was only detected in four (6.06%) and two (7.14%) isolates of C. parapsilosis sensu stricto and C. orthopsilosis, respectively. Sixty (90.91%) isolates of C. parapsilosis sensu stricto, 12 (42.86%) isolates of C. orthopsilosis, and all C. metapsilosis isolates showed phospholipase activity. Psuedohyphae formation was only detected in 33 (50%) and 15 (53.57%) isolates of C. parapsilosis sensu stricto and C. orthopsilosis, respectively. All isolates were susceptible to caspofungin. Most (85–100%) isolates were susceptible to antifungal drugs, but 3.13 – 6.25% were resistant to voriconazole and fluconazole. In conclusion, our findings revealed that C. parapsilosis sensu stricto was the most common species among clinical isolates of the C. parapsilosis complex, and the most commonly used antifungal agents generally exhibited good in vitro activity against these strains.

1 February 2020 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
SPSujiraphong Pharkjaksu
Sujiraphong Pharkjaksu
PCPiriyaporn Chongtrakool
Piriyaporn Chongtrakool
MCMethee Chayakulkeeree
Methee Chayakulkeeree
CMChalermchai Mitrpant
Chalermchai Mitrpant
PAPornpimon Angkasekwinai
Pornpimon Angkasekwinai
PNPopchai Ngamskulrungroj
Popchai Ngamskulrungroj
Introduction: The Cryptococcus neoformans/gattii species complexes are a leading cause of fatality among HIV-infected patients. Despite the unavailability of clinical breakpoints (CBPs) for antifungal agents, epidemiological cutoff values (ECVs) were recently proposed, and non-wild-type isolates for polyenes and azoles are being increasingly reported. However, the distributions of the susceptibility patterns for pre-HIV-era isolates have not been studied. Methods: We determined the in vitro antifungal susceptibility patterns of 233 Cryptococcus isolates, collected at the National Institutes of Health, USA, in pre-HIV pandemic era, to study minimum inhibitory concentrations (MICs) to the important drugs for cryptococcosis and to compare the results with strain genotypes. Amphotericin B susceptibility was compared to published ECV of C. neoformans. Results: The 233 Cryptococcus strains consisted of 89.7% C. neoformans species complex and 10.3% C. gattii species complex. Most were from clinical sources (189, 81.1%), and the major molecular type was VNI (146, 62.7%). The highest geometric mean (GM) was observed for fluconazole (GM = 0.96 μg/mL) while the lowest was for itraconazole (GM = 0.10 μg/mL). MICs to fluconazole in C. gattii species complex were significantly higher than C. neoformans species complex (p < 0.001). Moreover, C. neoformans/VNI strains showed significantly higher MICs than others such as C. neoformans/VNII to fluconazole (p < 0.0001) and C. deneoformans/VNIV to amphotericin B (p = 0.022) and fluconazole (p = 0.008). In our collection of 167 clinical C. neoformans species complex strains, 85 (50.9%), 24 (14.4%), and 3 (1.8%) strains had an amphotericin B (AMB)-MIC of 1, 2, and 4 μg/mL, respectively. The high percentage (66.9%, 79/118 strains) of non-wild-type clinical C. neoformans VNI strains, using an AMB-ECV of 0.5 μg/mL, was found. Moreover, 25 of 28 (89.3%) C. neoformans VNI strains from environmental and veterinary sources also had AMB-MICs above 0.5 μg/mL. In general, there was no significant difference in GM AMB-MIC of the clinical strains isolated from patients with (35 patients) and without (78 patients) prior AMB treatment (0.85 vs 0.76; p = 0.624). GM MIC of the environmental strains was not significantly different from that of the prior AMB-treatment strains (0.98 vs 0.76, p = 0.159) and the post-AMB-treatment strains (0.98 vs 0.85, p = 0.488). Conclusion: The high rate of non-wild-type among these otherwise naive isolates to amphotericin B is unexpected. Confirmation with more strains from a later era is needed.